Abstract
Introduction
Canis lupus familiaris is a domestic dog and many owners consider their pets as a family member. Medical bills with dogs are overcame only by the health care received by humans. Medical care is constantly progressing, and so is veterinary care. Metabolomics is the ‘‘omic” technique aimed to the study of metabolome, low-molecular weight molecules, through biofluids or tissue samples. And it also allows to evaluate disease diagnosis and prognosis, therapeutic evaluation and toxicological studies.
Objectives
The goal of this paper is to review the current and potential applications of metabolomics in domestic dogs.
Method
ScienceDirect, Scopus, Reaxys and PubMed were searched for papers that performed canine metabolomics in any research area.
Results
We analysed 38 papers, published until April 2019 in canine metabolomics approach. Metabolomic research in dogs so far can be divided into three areas: (a) Metabolomics studies in veterinary science, such as improving pet dogs health and welfare. (b) Diet, breeds and species discrimination. (c) Use of dogs as animal model in different diseases and drug development (evaluation toxicity and effect).
Conclusions
The results of this review showed that interest in metabolomics is growing in veterinary research. Several canine diseases have been evaluated with some promise for potential biomarker and/or disease mechanism discovery. Because canine metabolomics is a relatively new area, the researches spread across different research areas and with few studies in each area.
This is a preview of subscription content, log in via an institution to check access.
References
Abdullah, M., Kornegay, J. N., Honcoop, A., Parry, T. L., Balog-Alvarez, C. J., O’Neal, S. K., et al. (2017). Non-targeted metabolomics analysis of Golden Retriever Muscular Dystrophy-affected muscles reveals alterations in arginine and proline metabolism, and elevations in glutamic and oleic acid in vivo. Metabolites,7(3), 1–19. https://doi.org/10.3390/metabo7030038.
Allaway, D., Kamlage, B., Gilham, M. S., Hewson-Hughes, A. K., Wiemer, J. C., Colyer, A., et al. (2013). Effects of dietary glucose supplementation on the fasted plasma metabolome in cats and dogs. Metabolomics,9(5), 1096–1108. https://doi.org/10.1007/s11306-013-0527-8.
AMA, A. M. A. (2016). PET OWNERSHIP in Australia | 2016. https://animalmedicinesaustralia.org.au/wp-content/uploads/2016/11/AMA_Pet-Ownership-in-Australia-2016-Report_sml.pdf
APPA, A. P. P. A. (2018). APPA National Pet Owners Survey 2017–2018. https://americanpetproducts.org/Uploads/MemServices/GPE2017_NPOS_Seminar.pdf
Beckmann, M., Enot, D. P., Overy, D. P., Scott, I. M., Jones, P. G., Allaway, D., et al. (2010). Metabolite fingerprinting of urine suggests breed-specific dietary metabolism differences in domestic dogs. British Journal of Nutrition,103(8), 1127–1138. https://doi.org/10.1017/S000711450999300X.
Bodrug, S. E., Burghes, A. H. M., Bobrow, M., Harper, P. S., Thompson, M. W., Ray, P. N., et al. (1988). Frame-shift deletions in patients with Duchenne and Becker muscular dystrophy. Science,242(4879), 755–759.
Bollard, M. E., Keun, H. C., Beckonert, O., Ebbels, T. M. D., Antti, H., Nicholls, A. W., et al. (2005). Comparative metabonomics of differential hydrazine toxicity in the rat and mouse. Toxicology and Applied Pharmacology,204(2), 135–151. https://doi.org/10.1016/j.taap.2004.06.031.
Chandler, M., Cunningham, S., Lund, E. M., Khanna, C., Naramore, R., Patel, A., et al. (2017). Obesity and associated comorbidities in people and companion animals: A one health perspective. Journal of Comparative Pathology,156(4), 296–309. https://doi.org/10.1016/j.jcpa.2017.03.006.
Christians, U., Klawitter, J., Hornberger, A., & Klawitter, J. (2011). How unbiased is non-targeted metabolomics and is targeted pathway screening the solution? Current Pharmaceutical Biotechnology,12(7), 1053–1066.
Colyer, A., Gilham, M. S., Kamlage, B., Rein, D., & Allaway, D. (2011). Identification of intra- and inter-individual metabolite variation in plasma metabolite profiles of cats and dogs. British Journal of Nutrition,106(S1), S146–S149. https://doi.org/10.1017/S000711451100081X.
Corbee, R. J. (2013). Obesity in show dogs. Journal of Animal Physiology and Animal Nutrition,97(5), 904–910. https://doi.org/10.1111/j.1439-0396.2012.01336.x.
Courcier, E. A., Thomson, R. M., Mellor, D. J., & Yam, P. S. (2010). An epidemiological study of environmental factors associated with canine obesity. Journal of Small Animal Practice,51(7), 362–367. https://doi.org/10.1111/j.1748-5827.2010.00933.x.
Dai, L., Yang, W., Qin, X., Li, Y., Cao, H., Zhou, C., et al. (2019). Serum metabolomics profiling and potential biomarkers of myopia using LC-QTOF/MS. Experimental Eye Research,186, 107737. https://doi.org/10.1016/j.exer.2019.107737.
De Souza, A. I., Cardin, S., Wait, R., Chung, Y. L., Vijayakumar, M., Maguy, A., et al. (2010). Proteomic and metabolomic analysis of atrial profibrillatory remodelling in congestive heart failure. Journal of Molecular and Cellular Cardiology,49(5), 851–863. https://doi.org/10.1016/j.yjmcc.2010.07.008.
Dettmer, K., Almstetter, M. F., Appel, I. J., Nürnberger, N., Schlamberger, G., Gronwald, W., et al. (2010). Comparison of serum versus plasma collection in gas chromatography—Mass spectrometry-based metabolomics. Electrophoresis,31(14), 2365–2373. https://doi.org/10.1002/elps.200900778.
Djukovic, D., Gowda, G. A. N., Raftery, D., & Nmr, I. (2013). Mass spectrometry and nmr spectroscopy—Based quantitative metabolomics. In: Proteomic and metabolomic approaches to biomarker discovery (pp. 279–297). New York: Elsevier. https://doi.org/10.1016/B978-0-12-394446-7.00018-2.
Dumas, M. E., Maibaum, E. C., Teague, C., Ueshima, H., Zhou, B., Lindon, J. C., et al. (2006). Assessment of analytical reproducibility of 1H NMR spectroscopy based metabonomics for large-scale epidemiological research: The INTERMAP study. Analytical Chemistry,78(7), 2199–2208. https://doi.org/10.1021/ac0517085.
Ellis, D. I., Dunn, W. B., Griffin, J. L., Allwood, J. W., & Goodacre, R. (2007). Metabolic fingerprinting as a diagnostic tool. Pharmacogenomics,8(9), 1243–1266.
Emwas, A. H., Luchinat, C., Turano, P., Tenori, L., Roy, R., Salek, R. M., et al. (2015). Standardizing the experimental conditions for using urine in NMR-based metabolomic studies with a particular focus on diagnostic studies: A review. Metabolomics,11(4), 872–894. https://doi.org/10.1007/s11306-014-0746-7.
Fenaille, F., Saint-Hilaire, P. B., Rousseau, K., & Junot, C. (2017). Data acquisition workflows in liquid chromatography coupled to high resolution mass spectrometry-based metabolomics: Where do we stand? Journal of Chromatography A,1526, 1–12. https://doi.org/10.1016/j.chroma.2017.10.043.
Forster, G., Heuberger, A., Broeckling, C., Bauer, J., & Ryan, E. (2015). Consumption of cooked navy bean powders modulate the canine fecal and urine metabolome. Current Metabolomics,3(2), 90–101. https://doi.org/10.2174/2213235X03666150519234354.
Forster, G. M., Stockman, J., Noyes, N., Heuberger, A. L., Broeckling, C. D., Bantle, C. M., et al. (2018). A comparative study of serum biochemistry, metabolome and microbiome parameters of clinically healthy, normal weight, overweight, and obese companion dogs. Topics in Companion Animal Medicine,33(4), 126–135. https://doi.org/10.1053/j.tcam.2018.08.003.
German, A. J. (1946S). The WALTHAM International Nutritional Sciences Symposia. The growing problem of obesity in dogs and cats. The Journal of Nutrition,136(7 Suppl), 1940S–1946S. https://doi.org/10.1093/jn/136.7.1940S.
Gibney, M. J., Walsh, M., Brennan, L., Roche, H. M., German, B., & van Ommen, B. (2005). Metabolomics in human nutrition : opportunities and challenges. American Society for Clinical Nutrition,82, 497–503. https://doi.org/10.1093/ajcn.82.3.497.
Gika, H. G., Theodoridis, G. A., Plumb, R. S., & Wilson, I. D. (2014). Current practice of liquid chromatography–mass spectrometry in metabolomics and metabonomics. Journal of Pharmaceutical and Biomedical Analysis,87, 12–25. https://doi.org/10.1016/j.jpba.2013.06.032.
Gookin, J. L., Mathews, K. G., Cullen, J., & Seiler, G. (2018). Qualitative metabolomics profiling of serum and bile from dogs with gallbladder mucocele formation. PLoS ONE,13(1), 1–18. https://doi.org/10.1371/journal.pone.0191076.
Gopalan, V., Michael, N., Ishino, S., Lee, S. S., Yang, A. Y., Prakash, K. N. B., et al. (2016). Effect of exercise and calorie restriction on tissue acylcarnitines, tissue desaturase indices, and fat accumulation in diet-induced obese rats. Scientific Reports,6(April), 1–10. https://doi.org/10.1038/srep26445.
Guard, B. C., Barr, J. W., Reddivari, L., Klemashevich, C., Jayaraman, A., Steiner, J. M., et al. (2015). Characterization of microbial dysbiosis and metabolomic changes in dogs with acute diarrhea. PLoS ONE,10(5), 1–24. https://doi.org/10.1371/journal.pone.0127259.
Guennec, A. L., Tayyari, F., & Edison, A. S. (2017). Alternatives to nuclear overhauser enhancement spectroscopy presat and Carr–Purcell–Meiboom–Gill presat for NMR-based metabolomics. Analytical Chemistry,89, 8582–8588. https://doi.org/10.1021/acs.analchem.7b02354.
Hall, J. A., Brockman, J. A., & Jewell, D. E. (2011). Dietary fish oil alters the lysophospholipid metabolomic profile and decreases urinary 11-dehydro thromboxane B2concentration in healthy Beagles. Veterinary Immunology and Immunopathology,144(3–4), 355–365. https://doi.org/10.1016/j.vetimm.2011.08.007.
Han, J., Datla, R., Chan, S., & Borchers, C. H. (2009). Mass spectrometry-based technologies for high-throughput metabolomics. Bioanalysis,1(9), 1665–1684.
Holbrook, M. B. (2008). Pets and people: Companions in commerce? Journal of Business Research,61(5), 546–552. https://doi.org/10.1016/j.jbusres.2007.07.010.
Honneffer, J. B., Minamoto, Y., & Suchodolski, J. S. (2014). Microbiota alterations in acute and chronic gastrointestinal inflammation of cats and dogs. World Journal of Gastroenterology,20(44), 16489–16497. https://doi.org/10.3748/wjg.v20.i44.16489.
Honneffer, J. B., Steiner, J. M., Lidbury, J. A., & Suchodolski, J. S. (2017). Variation of the microbiota and metabolome along the canine gastrointestinal tract. Metabolomics,13(3), 1–20. https://doi.org/10.1007/s11306-017-1165-3.
Hytönen, M. K., & Lohi, H. (2016). Canine models of human rare disorders. Rare Diseases,4(1), e1241362. https://doi.org/10.1080/21675511.2016.1241362.
Jones, M. D., Rainville, P. D., Isaac, G., Wilson, I. D., Smith, N. W., & Plumb, R. S. (2014). Ultra high resolution SFC-MS as a high throughput platform for metabolic phenotyping: Application to metabolic profiling of rat and dog bile. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences,966, 200–207. https://doi.org/10.1016/j.jchromb.2014.04.017.
Karu, N., Deng, L., Slae, M., Guo, A. C., Sajed, T., Huynh, H., et al. (2018). A review on human fecal metabolomics: Methods, applications and the human fecal metabolome database. Analytica Chimica Acta,1030, 1–24. https://doi.org/10.1016/j.aca.2018.05.031.
Kirwan, J. (2013). Metabolomics for the practising vet. Diagnostics,35(September), 438–445. https://doi.org/10.1136/inp.f5259.
Koal, T., & Deigner, H. (2010). Challenges in mass spectrometry based targeted metabolomics. Current Molecular Medicine,10(2), 216–226. https://doi.org/10.2174/156652410790963312.
Kook, P. H., Boretti, F. S., Hersberger, M., Glaus, T. M., & Reusch, C. E. (2010). Urinary catecholamine and metanephrine to creatinine ratios in dogs with hyperadrenocorticism or pheochromocytoma, and in healthy dogs. Journal of Veterinary Internal Medicine,24(5), 1093–1097. https://doi.org/10.1111/j.1939-1676.2010.0578.x.
Kornegay, J. N., Bogan, D. J., Bogan, J. R., Childers, M. K., Cundiff, D. D., Petroski, G. F., et al. (1999). Contraction force generated by tarsal joint flexion and extension in dogs with golden retriever muscular dystrophy. Journal of the Neurological Sciences,166(166), 115–121.
Kuehnbaum, N. L., & Britz-mckibbin, P. (2013). New advances in separation science for metabolomics: Resolving chemical diversity in a post-genomic era. Chemical Reviews,113(4), 2437–2468. https://doi.org/10.1021/cr300484s.
Lee, W., Ko, B. J., Sim, Y. E., Suh, S., Yoon, D., & Kim, S. (2019). Discrimination of human urine from animal urine using 1 H-NMR. Journal of Analytical Toxicology,43(1), 51–60. https://doi.org/10.1093/jat/bky061.
Li, Q., Freeman, L. M., Rush, J. E., Huggins, G. S., Kennedy, A. D., Labuda, J. A., et al. (2015). Veterinary medicine and multi-omics research for future nutrition targets: Metabolomics and transcriptomics of the common degenerative mitral valve disease in dogs. OMICS A Journal of Integrative Biology,19(8), 461–470. https://doi.org/10.1089/omi.2015.0057.
Lindon, J. C., Holmes, E., & Nicholson, J. K. (2001). Pattern recognition methods and applications in biomedical magnetic resonance. Progress in Nuclear Magnetic Resonance Spectroscopy,39, 1–40.
Liu, L., Aa, J., Wang, G., Yan, B., Zhang, Y., Wang, X., et al. (2010). Differences in metabolite profile between blood plasma and serum. Analytical Biochemistry,406(2), 105–112. https://doi.org/10.1016/j.ab.2010.07.015.
Liu, X., Hoene, M., Wang, X., Yin, P., Häring, H. U., Xu, G., et al. (2018). Serum or plasma, what is the difference? Investigations to facilitate the sample material selection decision making process for metabolomics studies and beyond. Analytica Chimica Acta,1037, 293–300. https://doi.org/10.1016/j.aca.2018.03.009.
Lloyd, A. J., Beckmann, M., Tailliart, K., Brown, W. Y., Draper, J., & Allaway, D. (2016). Characterisation of the main drivers of intra- and inter- breed variability in the plasma metabolome of dogs. Metabolomics. https://doi.org/10.1007/s11306-016-0997-6.
Lloyd, A. J., Beckmann, M., Wilson, T., Tailliart, K., Allaway, D., & Draper, J. (2017). Ultra high performance liquid chromatography–high resolution mass spectrometry plasma lipidomics can distinguish between canine breeds despite uncontrolled environmental variability and non-standardized diets. Metabolomics,13(2), 1–11. https://doi.org/10.1007/s11306-016-1152-0.
Lund, E. M., Armstrong, P. J., Kirk, C. A., & Klausner, J. S. (2006). Prevalence and risk factors for obesity in adult dogs from private US veterinary practices. International Journal of Applied Research in Veterinary Medicine,4(2), 177–186.
Mao, J., Xia, Z., Chen, J., & Yu, J. (2013). Prevalence and risk factors for canine obesity surveyed in veterinary practices in Beijing China. Preventive Veterinary Medicine,112(3–4), 438–442. https://doi.org/10.1016/j.prevetmed.2013.08.012.
Martini, F. M., Brandstetter de Bellesini, A., Miolo, A., Del Coco, L., Fanizzi, F. P., & Crovace, A. (2017). Combining a joint health supplement with tibial plateau leveling osteotomy in dogs with cranial cruciate ligament rupture. An exploratory controlled trial. International Journal of Veterinary Science and Medicine,5(2), 105–112. https://doi.org/10.1016/j.ijvsm.2017.09.006.
McGreevy, P. D., Thomson, P. C., Pride, C., Fawcett, A., Grassi, T., & Jones, B. (2005). Prevalence of obesity in dogs examined by Australian veterinary practices and the risk factors involved. Veterinary Record,156(22), 695–702. https://doi.org/10.1136/vr.156.22.695.
Minamoto, Y., Otoni, C. C., Steelman, S. M., Steiner, J. M., Jergens, A. E., Suchodolski, J. S., et al. (2015). Alteration of the fecal microbiota and serum metabolite profiles in dogs with idiopathic inflammatory bowel disease Alteration of the fecal microbiota and serum metabolite profiles in dogs with idiopathic in flammatory bowel disease. Gut Microbes,6(1), 33–47. https://doi.org/10.1080/19490976.2014.997612.
Morvan, D., & Demidem, A. (2007). Metabolomics by proton nuclear magnetic resonance spectroscopy of the response to chloroethylnitrosourea reveals drug efficacy and tumor adaptive metabolic pathways. Cancer Research,67(5), 2150–2159. https://doi.org/10.1158/0008-5472.CAN-06-2346.
Musteata, M., Nicolescu, A., Solcan, G., & Deleanu, C. (2013). The 1H NMR profile of healthy dog cerebrospinal fluid. PLoS ONE,8(12), 12–14. https://doi.org/10.1371/journal.pone.0081192.
Nicholson, J. K., Connelly, J., Lindon, J. C., & Holmes, E. (2002). Metabonomics: A platform for studying drug toxicity and gene function. Nature Reviews Drug Discovery,1(2), 153–161. https://doi.org/10.1038/nrd728.
Nicholson, J. K., Lindon, J. C., & Holmes, E. (1999). “Metabonomics”: Understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica,29(11), 1181–1189. https://doi.org/10.1080/004982599238047.
Nicholson, J. K., & Wilson, I. A. N. D. (1989). High resolution proton magnetic resonance spectroscopy of biological fluids. Progress in NMR Spectroscopy,21, 449–501.
O’Gorman, A., & Brennan, L. (2015). Metabolomic applications in nutritional research: A perspective. Journal of the Science of Food and Agriculture,95, 2567–2570. https://doi.org/10.1002/jsfa.7070.
O’Kell, A. L., Garrett, T. J., & Atkinson, C. W. M. A. (2019). Untargeted metabolomic analysis in non-fasted diabetic dogs by UHPLC – HRMS. Metabolomics,15(15), 1–6. https://doi.org/10.1007/s11306-019-1477-6.
O’Kell, A. L., Garrett, T. J., Wasserfall, C., & Atkinson, M. A. (2017). Untargeted metabolomic analysis in naturally occurring canine diabetes mellitus identifies similarities to human Type 1 Diabetes. Scientific Reports,7(1), 1–7. https://doi.org/10.1038/s41598-017-09908-5.
Osaki, T., Azuma, K., Kurozumi, S., Takamori, Y., Tsuka, T., Imagawa, T., et al. (2012). Metabolomic analyses of blood plasma after oral administration of d-glucosamine hydrochloride to dogs. Marine Drugs,10(8), 1873–1882. https://doi.org/10.3390/md10081873.
Osaki, T., Kurozumi, S., Sato, K., Terashi, T., Azuma, K., Murahata, Y., et al. (2015). Metabolomic analysis of blood plasma after oral administration of N-acetyl-d-glucosamine in dogs. Marine Drugs,13(8), 5007–5015. https://doi.org/10.3390/md13085007.
Overall, K. L. (2000). Natural animal models of human psychiatric conditions: Assessment of mechanism and validity. Progress in Neuro-Psychopharmacology and Biological Psychiatry,24(5), 727–776. https://doi.org/10.1016/S0278-5846(00)00104-4.
Packey, C. D., & Sartor, R. B. (2009). Commensal bacteria, traditional and opportunistic pathogens, dysbiosis and bacterial killing in inflammatory bowel diseases. Current Opinion in Infectious Diseases,22(3), 292–301. https://doi.org/10.1097/QCO.0b013e32832a8a5d.
Patterson, D. F. (2000). Companion animal medicine in the age of medical genetics. Journal of Veterinary Internal Medicine,14, 1–9.
Pauling, L., Robinson, A. B., Teranishit, R., & Cary, P. (1971). Quantitative analysis of urine vapor and breath by gas-liquid partition chromatography. Proceedings of the National Academy of Sciences,68(10), 2374–2376.
Plumb, R. S., Rainville, P. D., Potts, W. B., Johnson, K. A., Gika, E., & Wilson, I. D. (2009). Application of ultra performance liquid chromatography-mass spectrometry to profiling rat and dog bile. Journal of Proteome Research,8(5), 2495–2500. https://doi.org/10.1021/pr801078a.
Puurunen, J., Sulkama, S., Tiira, K., Araujo, C., Lehtonen, M., Hanhineva, K., et al. (2016a). A non-targeted metabolite profiling pilot study suggests that tryptophan and lipid metabolisms are linked with ADHD-like behaviours in dogs. Behavioral and Brain Functions,12(1), 1–13. https://doi.org/10.1186/s12993-016-0112-1.
Puurunen, J., Tiira, K., Lehtonen, M., Hanhineva, K., & Lohi, H. (2016b). Non-targeted metabolite profiling reveals changes in oxidative stress, tryptophan and lipid metabolisms in fearful dogs. Behavioral and Brain Functions,12(1), 1–12. https://doi.org/10.1186/s12993-016-0091-2.
Rowell, J. L., McCarthy, D. O., & Alvarez, C. E. (2011). Dog models of naturally occurring cancer. Trends in Molecular Medicine,17(7), 380–388. https://doi.org/10.1016/j.molmed.2011.02.004.
Schmidt, M., Unterer, S., Suchodolski, J. S., Honneffer, J. B., Guard, B. C., Lidbury, J. A., et al. (2018). The fecal microbiome and metabolome differs between dogs fed Bones and Raw Food (BARF) diets and dogs fed commercial diets. PLoS ONE,13(8), 1–20. https://doi.org/10.1371/journal.pone.0201279.
Shibayama, J., Taylor, T. G., Venable, P. W., Rhodes, N. L., Gil, R. B., Warren, M., et al. (2013). Metabolic determinants of electrical failure in ex-vivo canine model of cardiac arrest: Evidence for the protective role of inorganic pyrophosphate. PLoS ONE. https://doi.org/10.1371/journal.pone.0057821.
Shibayama, J., Yuzyuk, T. N., Cox, J., Makaju, A., Miller, M., Lichter, J., et al. (2015). Metabolic remodeling in moderate synchronous versus dyssynchronous pacing-induced heart failure: Integrated metabolomics and proteomics study. PLoS ONE,10(3), 1–32. https://doi.org/10.1371/journal.pone.0118974.
Smith, D., Broadhead, C., Descotes, G., Fosse, R., Hack, R., Krauser, K., et al. (2002). Preclinical safety evaluation using nonrodent species: An industry/welfare project to minimize dog use. ILAR Journal,43, S29–S42.
Söbbeler, F. J., Carrera, I., Pasloske, K., Ranasinghe, M. G., Kircher, P., & Kästner, S. B. R. (2018). Effects of isoflurane, sevoflurane, propofol and alfaxalone on brain metabolism in dogs assessed by proton magnetic resonance spectroscopy (1H MRS). BMC Veterinary Research,14(1), 1–15. https://doi.org/10.1186/s12917-018-1396-1.
Soder, J., Hagman, R., Dicksved, J., Lindase, S., Malmlof, K., Agback, P., et al. (2017). The urine metabolome differs between lean and overweight Labrador Retriever dogs during a feed-challenge. PLoS ONE,12(6), 1–17. https://doi.org/10.1371/journal.pone.0180086.
Spratlin, J. L., Serkova, N. J., & Eckhardt, S. G. (2009). Clinical applications of metabolomics in oncology: A review. Clinical Cancer Research,15(2), 431–440. https://doi.org/10.1158/1078-0432.CCR-08-1059.
Starkey, M. P., Scase, T. J., Mellersh, C. S., & Murphy, S. (2005). Dogs really are man’s best friend—Canine genomics has applications in veterinary and human medicine! Briefings in Functional Genomics and Proteomics,4(2), 112–128. https://doi.org/10.1093/bfgp/4.2.112.
Suchodolski, J. S., Markel, M. E., Garcia-Mazcorro, J. F., Unterer, S., Heilmann, R. M., Dowd, S. E., et al. (2012). The fecal microbiome in dogs with acute diarrhea and idiopathic inflammatory bowel disease. PLoS ONE. https://doi.org/10.1371/journal.pone.0051907.
Sulek, K., Frandsen, H. L., Smedsgaard, J., Skov, T. H., Wilcks, A., & Licht, T. R. (2012). Metabolic footprint of Lactobacillus acidophilus NCFM at different pH. Metabolomics,8, 244–252. https://doi.org/10.1007/s11306-011-0305-4.
Suravajhala, P., Kogelman, L. J. A., & Kadarmideen, H. N. (2016). Multi-omic data integration and analysis using systems genomics approaches: Methods and applications in animal production, health and welfare. Genetics Selection Evolution,48(1), 38. https://doi.org/10.1186/s12711-016-0217-x.
Tamai, R., Furuya, M., Hatoya, S., Akiyoshi, H., Yamamoto, R., Komori, Y., et al. (2014). Profiling of serum metabolites in canine lymphoma using gas chromatography mass spectrometry. Journal of Veterinary Medical Science,76(11), 1513–1518. https://doi.org/10.1292/jvms.14-0043.
Toledo, F. G. S., & Delany, J. P. (2014). Diabetes and identification of a marker of glucolipotoxicity. Obesity,18(9), 1695–1700. https://doi.org/10.1038/oby.2009.510.Increased.
Van Meer, P. J. K., Graham, M. L., & Schuurman, H. J. (2015). The safety, efficacy and regulatory triangle in drug development: Impact for animal models and the use of animals. European Journal of Pharmacology,759, 3–13. https://doi.org/10.1016/j.ejphar.2015.02.055.
Viant, M. R., Ludwig, C., Rhodes, S., Günther, U. L., & Allaway, D. (2007). Validation of a urine metabolome fingerprint in dog for phenotypic classification. Metabolomics,3(4), 453–463. https://doi.org/10.1007/s11306-007-0092-0.
Wagoner, M. P., Yang, Y., McDuffie, J. E., Klapczynski, M., Buck, W., Cheatham, L., et al. (2017). Evaluation of temporal changes in urine-based metabolomic and kidney injury markers to detect compound induced acute kidney tubular toxicity in beagle dogs. Current Topics in Medicinal Chemistry,17(24), 2767–2780. https://doi.org/10.2174/1568026617666170713172331.
Wang, Y., Lawler, D., Larson, B., Ramadan, Z., Kochhar, S., Holmes, E., et al. (2007). Metabonomic investigations of aging and caloric restriction in a life-long dog study. Journal of Proteome Research,6(5), 1846–1854. https://doi.org/10.1021/pr060685n.
Wang, G. D., Zhai, W., Yang, H. C., Fan, R. X., Cao, X., Zhong, L., et al. (2013). The genomics of selection in dogs and the parallel evolution between dogs and humans. Nature Communications,4(May), 1860–1869. https://doi.org/10.1038/ncomms2814.
Wang, G.-D., Zhai, W., Yang, H.-C., Wang, L., Zhong, L., Liu, Y.-H., et al. (2016). Out of southern East Asia: The natural history of domestic dogs across the world. Cell Research,26(1), 21–33. https://doi.org/10.1038/cr.2015.147.
Wayne, R. K., & Ostrander, E. A. (2007). Lessons learned from the dog genome. Trends in Genetics,23(11), 557–567. https://doi.org/10.1016/j.tig.2007.08.013.
Whitfield, P. D., Noble, P. J. M., Major, H., Beynon, R. J., Burrow, R., Freeman, A. I., et al. (2005). Metabolomics as a diagnostic tool for hepatology: Validation in a naturally occurring canine model. Metabolomics,1(3), 215–225. https://doi.org/10.1007/s11306-005-0001-3.
Yan, G., Zhao, Y., Deng, P., Lv, L., Wang, Y., Bu, Q., et al. (2010). Investigation of toxicological effects of Shuanghuanglian injection in Beagle dogs by metabonomic and traditional approaches. Experimental Biology and Medicine,235(11), 1356–1364. https://doi.org/10.1258/ebm.2010.009390.
Yu, Z., Kastenmüller, G., He, Y., Belcredi, P., Möller, G., Prehn, C., et al. (2011). Differences between human plasma and serum metabolite profiles. PLoS ONE,6(7), 1–6. https://doi.org/10.1371/journal.pone.0021230.
Zhang, H., Patrone, L., Kozlosky, J., Tomlinson, L., Cosma, G., & Horvath, J. (2010). Pooled sample strategy in conjunction with high-resolution liquid chromatography-mass spectrometry-based background subtraction to identify toxicological markers in dogs treated with ibipinabant. Analytical Chemistry,82(9), 3834–3839. https://doi.org/10.1021/ac100287a.
Zhang, A., Sun, H., Wang, P., Han, Y., & Wang, X. (2012a). Recent and potential developments of biofluid analyses in metabolomics. Journal of Proteomics,75(4), 1079–1088. https://doi.org/10.1016/j.jprot.2011.10.027.
Zhang, J., Wei, S., Liu, L., Nagana Gowda, G. A., Bonney, P., Stewart, J., et al. (2012b). NMR-based metabolomics study of canine bladder cancer. Biochimica et Biophysica Acta - Molecular Basis of Disease,1822(11), 1807–1814. https://doi.org/10.1016/j.bbadis.2012.08.001.
Zhang, X., Xu, L., Shen, J., Cao, B., Cheng, T., Zhao, T., et al. (2013). Metabolic signatures of esophageal cancer: NMR-based metabolomics and UHPLC-based focused metabolomics of blood serum. Biochimica et Biophysica Acta - Molecular Basis of Disease,1832(8), 1207–1216. https://doi.org/10.1016/j.bbadis.2013.03.009.
Funding
This study was funded in part by the Coordenacão de Aperfeiçoamento de Pessoal de Nível Superior - Brasil (CAPES) - Finance Code 001.
Author information
Authors and Affiliations
Contributions
GC, FPS and PEF conceived and designed this review. GC wrote the manuscript. All authors read and approved the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Carlos, G., dos Santos, F.P. & Fröehlich, P.E. Canine metabolomics advances. Metabolomics 16, 16 (2020). https://doi.org/10.1007/s11306-020-1638-7
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11306-020-1638-7